Researchers from Caltech and UCLA have developed a new approach targeting Aging Mitochondrial DNA to remove cellular damage that accumulates with age. Led by Nikolay Kandul, senior postdoctoral scholar in biology and biological engineering in the la ...
Beyond the critical need for securing more study volunteers across the board in clinical trials, a popular concern in all areas of clinical research is achieving inclusion in clinical trials and promoting diversity. Whether in medical journals, po ...
The pharmaceutical market in Colombia is set to rise from $5 billion in 2015 to $7.1 billion by 2020, registering a compound annual growth rate (CAGR) of 7.3%, according to research and consulting firm GlobalData. The company’s latest report state ...
FOMAT Medical is a specialist in Phase 2, 3 & Phase 4 clinical trials in South America. FOMAT is a Site Management Organization providing services that specialize in the development and management of clinical trials. We meet expectations by conc ...
Ivan Solt, Anna Tomin, Krisztian Niesz, ChemAxon Ltd. Virtual screening (VS) aims to reduce the enormous virtual space of chemical compounds (a practical virtual library might comprise ~1015 molecules) to a more manageable number for further synthes ...
Scientists at the National Institutes of Health have solved a long-standing mystery about the origin of one of the cell types that make up the ovary. The team also discovered how ovarian cells share information during development of an ovarian follic ...
GAZETTE: Where are we with Alzheimer’s, medically and scientifically? TANZI: We’re a lot farther along now than we were even last year. Back in 1986, as a Harvard student in the graduate school, my doctoral study was to discover the first Alzheime ...
People with depression or bipolar disorder often feel their thinking ability has gotten “fuzzy”, or less sharp than before their symptoms began. Now, researchers have shown in a very large study that effect is indeed real – and rooted in brain activi ...
A distinct pattern in the changing length of blood telomeres, the protective end caps on our DNA strands, can predict cancer many years before actual diagnosis, according to a new study from Northwestern Medicine in collaboration with Harvard Univers ...
Using stem cells and gene editing, Salk Institute researchers have unearthed a major driver of aging research, from cancer to diabetes. That driver: loss of heterochromatin, which is potentially reversible as it is an epigenetic process that does not ...